AnaptysBio, Inc.ANABNASDAQ
LOADING
|||
Switch Symbol:
Gross Profit Growth Accelerating
Trending higher, above historical average.
Left:
||||
Year-over-year gross profit growth rate
Latest
388.63%
↑ 299% above average
Average (39q)
-195.59%
Historical baseline
Range
High:4293.75%
Low:-3226.47%
CAGR
NaN%
Modest growth trend
| Period | Value |
|---|---|
| Q3 2025 | 388.63% |
| Q2 2025 | -16.05% |
| Q1 2025 | -2658.97% |
| Q4 2024 | 104.30% |
| Q3 2024 | 60.69% |
| Q2 2024 | -3.89% |
| Q1 2024 | -21.79% |
| Q4 2023 | 11.03% |
| Q3 2023 | 6.46% |
| Q2 2023 | 12.27% |
| Q1 2023 | -102.72% |
| Q4 2022 | 20.24% |
| Q3 2022 | -5.82% |
| Q2 2022 | 8.90% |
| Q1 2022 | 16.37% |
| Q4 2021 | -1835.76% |
| Q3 2021 | -128.24% |
| Q2 2021 | 136.43% |
| Q1 2021 | -133.66% |
| Q4 2020 | 296.67% |
| Q3 2020 | -8.88% |
| Q2 2020 | -200.74% |
| Q1 2020 | 67.61% |
| Q4 2019 | 38.44% |
| Q3 2019 | -33.92% |
| Q2 2019 | -8.33% |
| Q1 2019 | -29.59% |
| Q4 2018 | -23.57% |
| Q3 2018 | -21.73% |
| Q2 2018 | 10.39% |
| Q1 2018 | -156.40% |
| Q4 2017 | 31.22% |
| Q3 2017 | -3166.83% |
| Q2 2017 | 97.42% |
| Q1 2017 | -250.80% |
| Q4 2016 | -3226.47% |
| Q3 2016 | -101.93% |
| Q2 2016 | 4293.75% |
| Q1 2016 | 103.18% |
| Q4 2015 | -1391.28% |